Background During a COVID-19 outbreak in the congregate shelter system in Halifax, Nova
Scotia, Canada, a healthcare team provided an emergency “safe supply” of medications and …

This review aimed to identify and synthesize strategies and actions adopted by addiction
facilities to support and maintain treatment during the coronavirus disease 2019 (COVID-19) …

The veterinary sedative xylazine is spreading in unregulated opioid supplies across North
America. Among people who use drugs with repeated exposure to xylazine, a distinct wound …

COVID-19 has resulted in deepened states of crisis and vulnerability for people who use
drugs throughout Europe and across the world, with social distancing measures having far …

Introduction Opioid overdose causes one in four deaths among people experiencing
homelessness in Boston, MA. To reduce overdose risks, the experience and perspectives of …

Background Harm reduction programs often lack community-based support and can be
controversial, despite data demonstrating effectiveness. This article describes one small …

From the outset of the COVID‐19 pandemic, fears have been raised worldwide regarding
the unique challenges facing socially marginalised people such as those who inject drugs …

Background The SARS-COV-2 pandemic rapidly shifted dynamics around hospitalization for
many communities. This study aimed to evaluate how the pandemic altered the experience …

Background Whereas supervised consumption services (SCSs) are common in many
community settings, they are seldomly found in acute care hospitals. As hospitals present …

Background Despite the widespread use of the phrase “harm reduction” and the proliferation
of programs based on its principles during the current opioid epidemic, what it means in …